August 17, 2016 In line with its strategy of growth through inorganic expansion, Zimmer Biomet Holdings, Inc. ZBH has gone for yet another mega acquisition. Earlier this week, this musculoskeletal major announced the buyout of CD Diagnostics, an immunoassays and biomarker testing developer, for an undisclosed term. This is not the first time Zimmer Biomet […]